BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

  June 8, 2026

   · 

  19 min read
• 

  Obesity

  ADA: Lilly sets ‘new record in Weight Loss Olympics’ with next-gen asset

  Over two years of treatment, Eli Lilly’s triple-G drug cut body weight by more than 30% in certain patients with obesity, cementing the pharma’s position as the frontrunner in the metabolic space.

  June 8, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market

  Much work needs to be done for Pfizer to be able to catch up to the weight-loss frontrunners, according to Guggenheim Partners, but new data from Metsera’s lead asset could set the pharma apart from competitors with a monthly injection.

  June 8, 2026

   · 

  4 min read

   · 

  Tristan Manalac
• Press Releases

  Drug Discovery Technology Market Size to Surpass USD 80.27 Billion by 2035

  June 8, 2026

   · 

  1 min read
• Press Releases

  Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026)

  June 8, 2026

   · 

  7 min read
• Press Releases

  Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

  June 8, 2026

   · 

  13 min read
• Press Releases

  Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

  June 8, 2026

   · 

  8 min read
• Press Releases

  Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

  June 8, 2026

   · 

  5 min read
• Press Releases

  Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

  June 8, 2026

   · 

  5 min read
• Press Releases

  Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

  June 8, 2026

   · 

  5 min read